[go: up one dir, main page]

SE0301882D0 - New use I - Google Patents

New use I

Info

Publication number
SE0301882D0
SE0301882D0 SE0301882A SE0301882A SE0301882D0 SE 0301882 D0 SE0301882 D0 SE 0301882D0 SE 0301882 A SE0301882 A SE 0301882A SE 0301882 A SE0301882 A SE 0301882A SE 0301882 D0 SE0301882 D0 SE 0301882D0
Authority
SE
Sweden
Prior art keywords
wound healing
new use
promoting wound
inhibitor
mammal
Prior art date
Application number
SE0301882A
Other languages
Swedish (sv)
Inventor
Cecilia Nilsson
Catrine Nilsson
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Priority to SE0301882A priority Critical patent/SE0301882D0/en
Publication of SE0301882D0 publication Critical patent/SE0301882D0/en
Priority to CNA2004800177434A priority patent/CN1812784A/en
Priority to PCT/SE2004/000996 priority patent/WO2004112784A1/en
Priority to JP2006517048A priority patent/JP2007521264A/en
Priority to EP04749034A priority patent/EP1638553A1/en
Priority to CA002529406A priority patent/CA2529406A1/en
Priority to AU2004249099A priority patent/AU2004249099A1/en
Priority to KR1020057024626A priority patent/KR20060023570A/en
Priority to NO20060416A priority patent/NO20060416L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

The invention relates to a method for promoting wound healing, said method comprising administering to a mammal, including man, in need of such promotion an effective amount of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1, wherein the said 11b-HSD1 inhibitor has the formula (I) wherein T, B, X, Y, R1 and R2 are as defined in the specification. These compounds may also be used in the manufacture of a medicament for promoting wound healing.
SE0301882A 2003-06-25 2003-06-25 New use I SE0301882D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE0301882A SE0301882D0 (en) 2003-06-25 2003-06-25 New use I
CNA2004800177434A CN1812784A (en) 2003-06-25 2004-06-21 New use i
PCT/SE2004/000996 WO2004112784A1 (en) 2003-06-25 2004-06-21 New use i
JP2006517048A JP2007521264A (en) 2003-06-25 2004-06-21 New Use I
EP04749034A EP1638553A1 (en) 2003-06-25 2004-06-21 New use i
CA002529406A CA2529406A1 (en) 2003-06-25 2004-06-21 New use i
AU2004249099A AU2004249099A1 (en) 2003-06-25 2004-06-21 New use I
KR1020057024626A KR20060023570A (en) 2003-06-25 2004-06-21 New Use I
NO20060416A NO20060416L (en) 2003-06-25 2006-01-25 New use I

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0301882A SE0301882D0 (en) 2003-06-25 2003-06-25 New use I

Publications (1)

Publication Number Publication Date
SE0301882D0 true SE0301882D0 (en) 2003-06-25

Family

ID=27656617

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0301882A SE0301882D0 (en) 2003-06-25 2003-06-25 New use I

Country Status (9)

Country Link
EP (1) EP1638553A1 (en)
JP (1) JP2007521264A (en)
KR (1) KR20060023570A (en)
CN (1) CN1812784A (en)
AU (1) AU2004249099A1 (en)
CA (1) CA2529406A1 (en)
NO (1) NO20060416L (en)
SE (1) SE0301882D0 (en)
WO (1) WO2004112784A1 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4789934B2 (en) 2004-05-24 2011-10-12 アムジエン・インコーポレーテツド Inhibitors of type 1 11-beta-hydroxysteroid dehydrogenase
US8686011B2 (en) 2004-05-24 2014-04-01 Amgen Inc. Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
GB0506133D0 (en) * 2005-03-24 2005-05-04 Sterix Ltd Compound
JP5140577B2 (en) 2005-03-31 2013-02-06 タケダ カリフォルニア インコーポレイテッド Hydroxysteroid dehydrogenase inhibitor
US7622492B2 (en) 2005-08-31 2009-11-24 Hoffmann-La Roche Inc. Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase
WO2007061661A2 (en) 2005-11-22 2007-05-31 Amgen Inc. Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
JP2010500300A (en) 2006-08-08 2010-01-07 サノフィ−アベンティス Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for their preparation, agents containing these compounds, and uses thereof
JP5098011B2 (en) * 2006-11-20 2012-12-12 国立大学法人山口大学 Wound healing promoter
DE102007005045B4 (en) 2007-01-26 2008-12-18 Sanofi-Aventis Phenothiazine derivatives, process for their preparation and their use as medicines
ES2523196T3 (en) * 2007-07-13 2014-11-21 Icagen, Inc. Sodium Channel Inhibitors
EP2025674A1 (en) 2007-08-15 2009-02-18 sanofi-aventis Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs
WO2010003624A2 (en) 2008-07-09 2010-01-14 Sanofi-Aventis Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
KR20120060207A (en) 2009-08-26 2012-06-11 사노피 Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
WO2011107494A1 (en) 2010-03-03 2011-09-09 Sanofi Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof
WO2011157827A1 (en) 2010-06-18 2011-12-22 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
WO2012120051A1 (en) 2011-03-08 2012-09-13 Sanofi Benzyl-oxathiazine derivates substituted with adamantane or noradamantane, medicaments containing said compounds and use thereof
EP2683701B1 (en) 2011-03-08 2014-12-24 Sanofi Oxathiazine derivatives substituted with benzyl or heteromethylene groups, method for their preparation, their usage as medicament, medicament containing same and its use
EP2766349B1 (en) 2011-03-08 2016-06-01 Sanofi Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
US8828994B2 (en) 2011-03-08 2014-09-09 Sanofi Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120055A1 (en) 2011-03-08 2012-09-13 Sanofi Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120056A1 (en) 2011-03-08 2012-09-13 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
EP2683702B1 (en) 2011-03-08 2014-12-24 Sanofi New substituted phenyl oxathiazine derivatives, method for their manufacture, medicines containing these compounds and their application
WO2012120057A1 (en) 2011-03-08 2012-09-13 Sanofi Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
US8828995B2 (en) 2011-03-08 2014-09-09 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
CN103204824B (en) * 2012-01-12 2015-04-08 清华大学深圳研究生院 2-aminothiazole-4-amide derivative, its preparation method and application
TW201512171A (en) 2013-04-19 2015-04-01 Pfizer Ltd Chemical compounds
CN105061288B (en) * 2015-08-07 2017-09-15 武汉华素康生物科技有限公司 Compound and its preparation method and application
EP3235813A1 (en) 2016-04-19 2017-10-25 Cidqo 2012, S.L. Aza-tetra-cyclo derivatives
CN118340765B (en) * 2024-04-30 2024-08-23 广州市朝利良生物科技有限公司 Application of benzamide compound in preparation of wound healing promoting medicine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH10639A (en) * 1967-07-17 1977-07-22 Research Corp Method of treatment and composition containing silver sulfadiazine
NZ306734A (en) * 1995-04-04 2000-01-28 Texas Biotechnology Corp
JP2001503037A (en) * 1996-10-16 2001-03-06 アメリカン・サイアナミド・カンパニー Preparation and use of ortho-sulfonamidoheteroarylhydroxamic acids as inhibitors of matrix metalloproteinases and tace
SE0001899D0 (en) * 2000-05-22 2000-05-22 Pharmacia & Upjohn Ab New compounds

Also Published As

Publication number Publication date
WO2004112784A1 (en) 2004-12-29
NO20060416L (en) 2006-03-24
JP2007521264A (en) 2007-08-02
KR20060023570A (en) 2006-03-14
AU2004249099A1 (en) 2004-12-29
CA2529406A1 (en) 2004-12-29
EP1638553A1 (en) 2006-03-29
CN1812784A (en) 2006-08-02

Similar Documents

Publication Publication Date Title
SE0301882D0 (en) New use I
SE0301886D0 (en) New use V
SE0301888D0 (en) New use VII
MY148690A (en) Novel macrocyclic inhibitors of hepatitis c virus replication
SE0101387D0 (en) Novel compounds
EA201000563A1 (en) TRIAZOLPYRIDINE INHIBITORS 11-BETA-HYDROXYSTEROID - DEHYDROGENASE TYPE I
ATE373474T1 (en) SUBSTITUTED 2-AMINOTETRALINE FOR THE TREATMENT OF DEPRESSION
IL192103A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
ATE384058T1 (en) THIAZOLE DERIVATIVES
NO20083032L (en) Use of benzofused heterocyclic sulfamide derivatives for the treatment of mania and bipolar disorder
CY1109763T1 (en) MATERIALS AND METHOD FOR TREATMENT OF CELLULAR DISORDERS
DK1664016T3 (en) Therapeutic agents useful for the treatment of pain
MXPA05000765A (en) 5-aryltetrazole compounds, compositions thereof, and uses therefor.
PE20030061A1 (en) 1-BIARIL-1,8-NAPHTHYRIDIN-4-ONA AS PHOSPHODIESTERASE-4 INHIBITORS
MY143568A (en) 11b-hsd1 inhibitors for the treatment of diabetes
DE602006010442D1 (en) USE OF BENZO-CONDENSED HETEROCYCLIC SULPHAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN
MXPA05010020A (en) Oxamide derivatives useful as raf-kinase inhibitors.
SE0301883D0 (en) New use II
SE0004101D0 (en) New use
SE0301885D0 (en) New use IV
SE0301884D0 (en) New use III
SE0002739D0 (en) New use
TW200600084A (en) Anti-coronavirus compounds
ATE308513T1 (en) NAPHTHAMIDE NEUROKININ ANTAGONISTS FOR USE AS MEDICATIONS
SE0201939D0 (en) New combination